i-Seq Biotechnology
PrivateLast Round
Grant
Jun 9, 2026
Total Funding Raised
$10,000
Company Overview
i-Seq Biotechnology operates in Healthcare & Life Sciences and is based in Mobile, Alabama. Its latest recorded funding round was a Grant round in June 2026.
i-Seq Biotechnology is a biotechnology company that develops novel, broad-spectrum vaccines and therapeutics against infectious disease pathogens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
i-Seq Biotechnology Comparables
Compare i-Seq Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReNewVax Ltd. | 80% | |
| Alterbiotix | 62% | |
| Abera Bioscience | 61% |
For institutional investors. Book with your work email.
i-Seq Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 9, 2026 | ||||
| Seed | Oct 15, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
i-Seq Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| INCATE | Grant |
| VIC Investor Network | Seed |
i-Seq Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about i-Seq Biotechnology's valuation, stock price, and market status.
Is i-Seq Biotechnology a public or private company?
i-Seq Biotechnology is a private company.
What is the current stock price of i-Seq Biotechnology?
i-Seq Biotechnology is a private company, so its shares have no public market price. Caplight tracks i-Seq Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is i-Seq Biotechnology worth (valuation)?
Valuation information for i-Seq Biotechnology is not publicly available.
Can I buy i-Seq Biotechnology stock?
i-Seq Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was i-Seq Biotechnology's last funding round?
i-Seq Biotechnology's most recent funding round was Grant on June 9, 2026.
Who are the main investors in i-Seq Biotechnology?
Key investors in i-Seq Biotechnology include INCATE, VIC Investor Network.
Will i-Seq Biotechnology IPO soon?
No public IPO plans have been announced for i-Seq Biotechnology.
How can I track i-Seq Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in i-Seq Biotechnology's shares on secondary markets.